Even though our study excluded anyone with known neurological or neurodegenerative conditions and even anyone with AD biomarkers and normal function, we found that increased tau-PET signal in our cohort was significantly associated with decreased memory performance. This evidence concerns the gene MAPT and Alzheimer disease.